An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

by Pollock RF, Meckley LM
Published 2018-04-01

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats

by Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, Scaife JG, Rao Y, Corral M
Published 2015-11-01